The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Radiopharmaceutical Solutions Market Research Report 2024
Synopsis
Global Radiopharmaceutical Solutions market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiopharmaceutical Solutions market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiopharmaceutical Solutions market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBA
GE Healthcare
Actinium Pharmaceuticals
Alseres Pharmaceuticals
Cardinal Health
Jubilant Pharma
Central Research Laboratories
Cyclomedica
Bracco
Eckert & Ziegler Radiopharma
Segment by Type
Oral Tracking
Vein Tracking
Segment by Application
Hospitals
Health Systems
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Radiopharmaceutical Solutions report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Radiopharmaceutical Solutions market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiopharmaceutical Solutions market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiopharmaceutical Solutions market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBA
GE Healthcare
Actinium Pharmaceuticals
Alseres Pharmaceuticals
Cardinal Health
Jubilant Pharma
Central Research Laboratories
Cyclomedica
Bracco
Eckert & Ziegler Radiopharma
Segment by Type
Oral Tracking
Vein Tracking
Segment by Application
Hospitals
Health Systems
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Radiopharmaceutical Solutions report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Tracking
1.2.3 Vein Tracking
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Health Systems
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Solutions Market Perspective (2018-2029)
2.2 Radiopharmaceutical Solutions Growth Trends by Region
2.2.1 Global Radiopharmaceutical Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceutical Solutions Market Dynamics
2.3.1 Radiopharmaceutical Solutions Industry Trends
2.3.2 Radiopharmaceutical Solutions Market Drivers
2.3.3 Radiopharmaceutical Solutions Market Challenges
2.3.4 Radiopharmaceutical Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Solutions Players by Revenue
3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Solutions Revenue
3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2022
3.5 Radiopharmaceutical Solutions Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Solutions Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Solutions Breakdown Data by Type
4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2029)
5 Radiopharmaceutical Solutions Breakdown Data by Application
5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiopharmaceutical Solutions Market Size (2018-2029)
6.2 North America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
6.4 North America Radiopharmaceutical Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Solutions Market Size (2018-2029)
7.2 Europe Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceutical Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceutical Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Solutions Market Size (2018-2029)
9.2 Latin America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBA
11.1.1 IBA Company Detail
11.1.2 IBA Business Overview
11.1.3 IBA Radiopharmaceutical Solutions Introduction
11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.1.5 IBA Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction
11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 Actinium Pharmaceuticals
11.3.1 Actinium Pharmaceuticals Company Detail
11.3.2 Actinium Pharmaceuticals Business Overview
11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.3.5 Actinium Pharmaceuticals Recent Development
11.4 Alseres Pharmaceuticals
11.4.1 Alseres Pharmaceuticals Company Detail
11.4.2 Alseres Pharmaceuticals Business Overview
11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.4.5 Alseres Pharmaceuticals Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Detail
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction
11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.5.5 Cardinal Health Recent Development
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Company Detail
11.6.2 Jubilant Pharma Business Overview
11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction
11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.6.5 Jubilant Pharma Recent Development
11.7 Central Research Laboratories
11.7.1 Central Research Laboratories Company Detail
11.7.2 Central Research Laboratories Business Overview
11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction
11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.7.5 Central Research Laboratories Recent Development
11.8 Cyclomedica
11.8.1 Cyclomedica Company Detail
11.8.2 Cyclomedica Business Overview
11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction
11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.8.5 Cyclomedica Recent Development
11.9 Bracco
11.9.1 Bracco Company Detail
11.9.2 Bracco Business Overview
11.9.3 Bracco Radiopharmaceutical Solutions Introduction
11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.9.5 Bracco Recent Development
11.10 Eckert & Ziegler Radiopharma
11.10.1 Eckert & Ziegler Radiopharma Company Detail
11.10.2 Eckert & Ziegler Radiopharma Business Overview
11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction
11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.10.5 Eckert & Ziegler Radiopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
